Discover 1,668 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,668
Active & Responsive
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
for
Generalized Myasthenia Gravis
Location: Chapel Hill NC, Winston-Salem NC, Charleston SC,
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Sex: All
Age: 18+
Code: NCT06463587
Phase 3, Recruiting
Active & Responsive
Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings
for
Suicide, Attempted, Suicide Ideation, Suicide,
Location: Chapel Hill NC, Baltimore MD, Philadelphia PA,
Sponsor: Johns Hopkins University
Sex: All
Age: 12 - 24
Code: NCT06151158
Recruiting
Active & Responsive
Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative
for
Stone, Kidney, Stone Ureter
Location: Chapel Hill NC, New York NY, Brooklyn NY,
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT05866081
Recruiting
Active & Responsive
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
for
Lower Extremity Acute Limb Ischemia, LE ALI
Location: Chapel Hill NC, Raleigh NC, Concord NC,
Sponsor: Penumbra Inc.
Sex: All
Age: 18+
Code: NCT06747117
Recruiting
Active & Responsive
CARED : A Novel Rapid Treatment Paradigm for Depression
for
Major Depressive Disorder
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18 - 70
Code: NCT07507370
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Chapel Hill NC, Reidsville NC, Greensboro NC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase 2, Recruiting
Active & Responsive
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Chapel Hill NC, Pinehurst NC, Richmond VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06589804
Phase 3, Recruiting
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: Chapel Hill NC, Raleigh NC, Fredericksburg VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase 3, Recruiting
Active & Responsive
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
for
Breast Cancer, Residual Disease,
Location: Chapel Hill NC, Birmingham AL
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT07069595
Phase 2, Recruiting
Active & Responsive
Daily Upgrade Trial
for
Healthy Women
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill
Sex: Female
Age: 25 - 45
Code: NCT07792603
Recruiting
Active & Responsive
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
for
Turner Syndrome, Short Stature Homeobox Gene Mutation,
Location: Chapel Hill NC, Charlottesville VA, Columbia SC,
Sponsor: Ascendis Pharma A/S
Sex: All
Age: 2 - 17
Code: NCT07221851
Phase 3, Recruiting
Active & Responsive
Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder
Location: Hillsborough NC, Columbus OH, New Brunswick NJ,
Sponsor: Timothy Voorhees
Sex: All
Age: 18+
Code: NCT05786040
Phase 2, Recruiting
Active & ResponsiveNew
Long-term Follow-up (LTFU) of Participants Who Received Azer-Cel
for
B-cell Mediated Autoimmune Disorders
Location: Morrisville NC
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 62
Code: NCT07577583
Recruiting
Active & Responsive
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
for
Spinal Muscular Atrophy (SMA)
Location: Hillsborough NC, New York NY, Hartford CT, Kissimmee FL,
Sponsor: argenx
Sex: All
Age: 5 - 17
Code: NCT07287982
Phase 2, Recruiting
Active & Responsive
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
for
Graves' Disease
Location: Cary NC, Macon GA, Bowling Green KY, Sayre PA,
Sponsor: Yarrow Bioscience, Inc.
Sex: All
Age: 18+
Code: NCT07682896
Phase 2, Recruiting
Active & Responsive
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
for
Graves' Disease, Graves Disease
Location: Raleigh NC, Asheville NC, Jacksonville FL, New York NY,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07570316
Phase 3, Recruiting
Active & Responsive
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
for
Hypertension
Location: Raleigh NC, Richmond VA, Mt. Pleasant SC, Lancaster PA,